Apomab and cognitive disorder Patient Reports February 10, 2012

Apomab Side Effects Report #5676445-9
Apomab side effect was reported by a Health Professional from UNITED STATES on Mar 13, 2008. Female patient, weighting 112.4 lb, was diagnosed with non-small cell lung cancer and was treated with Apomab. After drug was administered, patient experienced the following side effects: cognitive disorder. Apomab dosage: 765 MG, UNK. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, OLANZAPINE. Patient recovered.

Apomab Side Effects Report #5689253-X
Apomab side effect was reported by a Health Professional from UNITED STATES on Mar 20, 2008. Female patient, weighting 112.4 lb, was diagnosed with non-small cell lung cancer and was treated with Apomab. After drug was administered, patient experienced the following side effects: cognitive disorder. Apomab dosage: 765 MG, UNK. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, OLANZAPINE. Patient recovered.

Apomab Side Effects Report #5713058-4
Apomab side effect was reported by a Health Professional from UNITED STATES on Mar 31, 2008. Female patient, weighting 112.4 lb, was diagnosed with non-small cell lung cancer and was treated with Apomab. After drug was administered, patient experienced the following side effects: cognitive disorder, convulsion, mood swings. Apomab dosage: 765 MG, UNK. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, OLANZAPINE. Patient recovered.